JOURNAL ARTICLE

Reports Summarize Generalized Anxiety Disorders Research from Swinburne University of Technology [Neuroimaging Insights: Kava's (Piper methysticum) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder].

Published In: Mental Health Weekly Digest, 2023. P. 464 1 of 2
Database: Psychology Source 2 of 2

Abstract

A recent study conducted by researchers at Swinburne University of Technology in Melbourne, Australia, explored the effects of Kava (Piper methysticum) on the gamma-aminobutyric acid (GABA) levels in the dorsal anterior cingulate cortex (dACC) of individuals with Generalized Anxiety Disorder (GAD). The study found that participants who received Kava experienced a significant reduction in dACC GABA levels compared to those who received a placebo. The findings suggest that Kava may have an inhibitory effect on GABA levels, which could serve as a potential biomarker for diagnosis and treatment response in GAD. Further research is needed to fully understand the functional role of GABA levels in clinical anxiety and its potential for symptom benefit. [Extracted from the article]

Additional Information

Source:Mental Health Weekly Digest. 2023/12, p464
Document Type:Article
Subject Area:Health and Medicine
Publication Date:2023
ISSN:1543-6616
Accession Number:173745396
Copyright Statement:Copyright of Mental Health Weekly Digest is the property of NewsRx and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.